Myelo Therapeutics
Berlin
About Myelo Therapeutics
Myelo Therapeutics is focused on the development of treatments for a range of medical needs. It offers myelo001, a molecule that is effective on the hematogenesis. Myelo Therapeutics was founded by Till Erdmann in 2013. It is based in Berlin, Germany.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $17.4M
- Funding stage: Early Stage Venture
- Last round: Grant (Aug 2022)
- Website: myelotherapeutics.com
- Phone: [email protected]
Industries & Categories
Health Care, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/myelo-therapeutics-52499 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.